An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors' CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design
C. V. Herst, S. Burkholz, J. Sidney, A. Sette, P. E. Harris, S. Massey, T. Brasel, E. Cunha-Neto, D. S. Rosa, W. C. H. Chao, R. T. Carback, T. Hodge, L. Wang, S. Ciotlos, P. Lloyd, R. M. Rubsamen
The paper identifies a conserved Ebola Zaire epitope that provides protection in mice and suggests its potential application in COVID-19 vaccine design.
bioRxiv · Feb 25, 2020Immunology